Commissioning and validation of fluence-based 3D VMAT dose reconstruction system using new transmission detector.

In this study, we evaluated the basic performance of the three-dimensional dose verification system COMPASS (IBA Dosimetry). This system is capable of reconstructing 3D dose distributions on the patient anatomy based on the fluence measured using a new transmission detector (Dolphin, IBA Dosimetry) during treatment. The stability of the absolute dose and geometric calibrations of the COMPASS system with the Dolphin detector were investigated for fundamental validation. Furthermore, multileaf collimator (MLC) test patterns and a complicated volumetric modulated arc therapy (VMAT) plan were used to evaluate the accuracy of the reconstructed dose distributions determined by the COMPASS. The results from the COMPASS were compared with those of a Monte Carlo simulation (MC), EDR2 film measurement, and a treatment planning system (TPS). The maximum errors for the absolute dose and geometrical position were - 0.28% and 1.0 mm for 3 months, respectively. The Dolphin detector, which consists of ionization chamber detectors, was firmly mounted on the linear accelerator and was very stable. For the MLC test patterns, the TPS showed a > 5% difference at small fields, while the COMPASS showed good agreement with the MC simulation at small fields. However, the COMPASS produced a large error for complex small fields. For a clinical VMAT plan, COMPASS was more accurate than TPS. COMPASS showed real delivered-dose distributions because it uses the measured fluence, a high-resolution detector, and accurate beam modeling. We confirm here that the accuracy and detectability of the delivered dose of the COMPASS system are sufficient for clinical practice.

Three-dimensional gamma analysis of dose distributions in individual structures for IMRT dose verification.

Our purpose in this study was to implement three-dimensional (3D) gamma analysis for structures of interest such as the planning target volume (PTV) or clinical target volume (CTV), and organs at risk (OARs) for intensity-modulated radiation therapy (IMRT) dose verification. IMRT dose distributions for prostate and head and neck (HN) cancer patients were calculated with an analytical anisotropic algorithm in an Eclipse (Varian Medical Systems) treatment planning system (TPS) and by Monte Carlo (MC) simulation. The MC dose distributions were calculated with EGSnrc/BEAMnrc and DOSXYZnrc user codes under conditions identical to those for the TPS. The prescribed doses were 76 Gy/38 fractions with five-field IMRT for the prostate and 33 Gy/17 fractions with seven-field IMRT for the HN. TPS dose distributions were verified by the gamma passing rates for the whole calculated volume, PTV or CTV, and OARs by use of 3D gamma analysis with reference to MC dose distributions. The acceptance criteria for the 3D gamma analysis were 3/3 and 2 %/2 mm for a dose difference and a distance to agreement. The gamma passing rates in PTV and OARs for the prostate IMRT plan were close to 100 %. For the HN IMRT plan, the passing rates of 2 %/2 mm in CTV and OARs were substantially lower because inhomogeneous tissues such as bone and air in the HN are included in the calculation area. 3D gamma analysis for individual structures is useful for IMRT dose verification.

Monte Carlo calculation of patient organ doses from computed tomography.

In this study, we aimed to evaluate quantitatively the patient organ dose from computed tomography (CT) using Monte Carlo calculations. A multidetector CT unit (Aquilion 16, TOSHIBA Medical Systems) was modeled with the GMctdospp (IMPS, Germany) software based on the EGSnrc Monte Carlo code. The X-ray spectrum and the configuration of the bowtie filter for the Monte Carlo modeling were determined from the chamber measurements for the half-value layer (HVL) of aluminum and the dose profile (off-center ratio, OCR) in air. The calculated HVL and OCR were compared with measured values for body irradiation with 120 kVp. The Monte Carlo-calculated patient dose distribution was converted to the absorbed dose measured by a Farmer chamber with a (60)Co calibration factor at the center of a CT water phantom. The patient dose was evaluated from dose-volume histograms for the internal organs in the pelvis. The calculated Al HVL was in agreement within 0.3% with the measured value of 5.2 mm. The calculated dose profile in air matched the measured value within 5% in a range of 15 cm from the central axis. The mean doses for soft tissues were 23.5, 23.8, and 27.9 mGy for the prostate, rectum, and bladder, respectively, under exposure conditions of 120 kVp, 200 mA, a beam pitch of 0.938, and beam collimation of 32 mm. For bones of the femur and pelvis, the mean doses were 56.1 and 63.6 mGy, respectively. The doses for bone increased by up to 2-3 times that of soft tissue, corresponding to the ratio of their mass-energy absorption coefficients.

[Dose distribution from kV-cone beam computed tomography in image-guided radiotherapy].

Image-guided radiotherapy (IGRT) is an increasingly commonly adopted technique. As a result, however, total patient dose is increasing rapidly, especially when kV-cone beam computed tomography (CBCT) is applied. This study investigated the dosimetry of kV-CBCT using a Farmer ionization chamber with a (60)Co absorbed-dose calibration factor. The absorbed-dose measurements were performed using an I'mRT phantom (RW3, IBA) which is employed for dose verification of intensity-modulated radiotherapy (IMRT). The I'mRT phantom was used as a substitute for head and pelvis phantoms. The kV-CBCT absorbed dose was evaluated from a beam quality conversion factor of kV to (60)Co and the ionization ratio of the I'mRT phantom and water, calculated using the Monte Carlo method. The dose distribution in the I'mRT phantom was also measured using a radiophotoluminescent glass dosimeter (RGD). The absorbed doses for the pelvis phantom (full scan) ranged from 2.5-4 cGy for kV-CBCT and 4-8 cGy for MV-CBCT. TomoTherapy resulted in a lower dose of approximately 1.3 cGy due to fan-beam. For the head phantom (half scan), the doses ranged from 0.1-0.7 cGy for kV-CBCT and 3-5 cGy for MVCBCT. The results for RGD were similar to ion chamber measurements. It is necessary to decrease the absorbed dose of the organs at risk every time IGRT is applied.

[Physical characterizations for an integrated 160-leaf multi-leaf collimator with a new concept design].

In this article, we present a physical characterization of the agility(™) (Elekta). agility(™) is composed of 160 interdigitating multileaf collimators (MLCs) with a width of 5 mm at the isocenter. The physical characterizations that include leaf position accuracy, leakage, field penumbra and the tongue-and-groove (T&G) effect were evaluated using well-commissioned 4, 6 and 10-MV photon beams. The leaf position accuracy was within 0.5 mm for all gantry angles and each MLC. The leakage was 0.44% on average and reached 0.47% at 10 MV: remarkably low due to a new design with tilted leaves. However, the T&G effect occurred due to tilt. It was approximately 20.8% on average and reached 22.3% at 6 MV. The penumbra width increased up to 8.5 mm at a field size of 20×20 cm at 4 MV. High position designed MLCs create a wider penumbra but show lower leakage and large head clearance. Head clearance is an important factor in stereotactic radiotherapy with multiple non-coplanar beams.

[Comparison of dose calculation algorithms in stereotactic radiation therapy in lung].

Dose calculation algorithms in radiation treatment planning systems (RTPSs) play a crucial role in stereotactic body radiation therapy (SBRT) in the lung with heterogeneous media. This study investigated the performance and accuracy of dose calculation for three algorithms: analytical anisotropic algorithm (AAA), pencil beam convolution (PBC) and Acuros XB (AXB) in Eclipse (Varian Medical Systems), by comparison against the Voxel Monte Carlo algorithm (VMC) in iPlan (BrainLab). The dose calculations were performed with clinical lung treatments under identical planning conditions, and the dose distributions and the dose volume histogram (DVH) were compared among algorithms. AAA underestimated the dose in the planning target volume (PTV) compared to VMC and AXB in most clinical plans. In contrast, PBC overestimated the PTV dose. AXB tended to slightly overestimate the PTV dose compared to VMC but the discrepancy was within 3%. The discrepancy in the PTV dose between VMC and AXB appears to be due to differences in physical material assignments, material voxelization methods, and an energy cut-off for electron interactions. The dose distributions in lung treatments varied significantly according to the calculation accuracy of the algorithms. VMC and AXB are better algorithms than AAA for SBRT.